IBDEI20G ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,33676,0)
 ;;=Z71.89^^151^1681^2
 ;;^UTILITY(U,$J,358.3,33676,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33676,1,3,0)
 ;;=3^Other Spec Counseling
 ;;^UTILITY(U,$J,358.3,33676,1,4,0)
 ;;=4^Z71.89
 ;;^UTILITY(U,$J,358.3,33676,2)
 ;;=^5063253
 ;;^UTILITY(U,$J,358.3,33677,0)
 ;;=E11.9^^151^1682^5
 ;;^UTILITY(U,$J,358.3,33677,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33677,1,3,0)
 ;;=3^Diabetes Type 2 w/o Complications
 ;;^UTILITY(U,$J,358.3,33677,1,4,0)
 ;;=4^E11.9
 ;;^UTILITY(U,$J,358.3,33677,2)
 ;;=^5002666
 ;;^UTILITY(U,$J,358.3,33678,0)
 ;;=E10.9^^151^1682^3
 ;;^UTILITY(U,$J,358.3,33678,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33678,1,3,0)
 ;;=3^Diabetes Type 1 w/o Complications
 ;;^UTILITY(U,$J,358.3,33678,1,4,0)
 ;;=4^E10.9
 ;;^UTILITY(U,$J,358.3,33678,2)
 ;;=^5002626
 ;;^UTILITY(U,$J,358.3,33679,0)
 ;;=E11.65^^151^1682^4
 ;;^UTILITY(U,$J,358.3,33679,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33679,1,3,0)
 ;;=3^Diabetes Type 2 w/ Hyperglycemia
 ;;^UTILITY(U,$J,358.3,33679,1,4,0)
 ;;=4^E11.65
 ;;^UTILITY(U,$J,358.3,33679,2)
 ;;=^5002663
 ;;^UTILITY(U,$J,358.3,33680,0)
 ;;=E10.65^^151^1682^2
 ;;^UTILITY(U,$J,358.3,33680,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33680,1,3,0)
 ;;=3^Diabetes Type 1 w/ Hyperglycemia
 ;;^UTILITY(U,$J,358.3,33680,1,4,0)
 ;;=4^E10.65
 ;;^UTILITY(U,$J,358.3,33680,2)
 ;;=^5002623
 ;;^UTILITY(U,$J,358.3,33681,0)
 ;;=R73.09^^151^1682^1
 ;;^UTILITY(U,$J,358.3,33681,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33681,1,3,0)
 ;;=3^Abnormal Glucose
 ;;^UTILITY(U,$J,358.3,33681,1,4,0)
 ;;=4^R73.09
 ;;^UTILITY(U,$J,358.3,33681,2)
 ;;=^5019563
 ;;^UTILITY(U,$J,358.3,33682,0)
 ;;=Z79.4^^151^1682^6
 ;;^UTILITY(U,$J,358.3,33682,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33682,1,3,0)
 ;;=3^Long Term (Current) Use of Insulin
 ;;^UTILITY(U,$J,358.3,33682,1,4,0)
 ;;=4^Z79.4
 ;;^UTILITY(U,$J,358.3,33682,2)
 ;;=^5063334
 ;;^UTILITY(U,$J,358.3,33683,0)
 ;;=E66.9^^151^1683^5
 ;;^UTILITY(U,$J,358.3,33683,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33683,1,3,0)
 ;;=3^Obesity,Unspec
 ;;^UTILITY(U,$J,358.3,33683,1,4,0)
 ;;=4^E66.9
 ;;^UTILITY(U,$J,358.3,33683,2)
 ;;=^5002832
 ;;^UTILITY(U,$J,358.3,33684,0)
 ;;=E66.01^^151^1683^2
 ;;^UTILITY(U,$J,358.3,33684,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33684,1,3,0)
 ;;=3^Morbid Obesity d/t Excess Calories
 ;;^UTILITY(U,$J,358.3,33684,1,4,0)
 ;;=4^E66.01
 ;;^UTILITY(U,$J,358.3,33684,2)
 ;;=^5002826
 ;;^UTILITY(U,$J,358.3,33685,0)
 ;;=E66.3^^151^1683^6
 ;;^UTILITY(U,$J,358.3,33685,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33685,1,3,0)
 ;;=3^Overweight
 ;;^UTILITY(U,$J,358.3,33685,1,4,0)
 ;;=4^E66.3
 ;;^UTILITY(U,$J,358.3,33685,2)
 ;;=^5002830
 ;;^UTILITY(U,$J,358.3,33686,0)
 ;;=E66.09^^151^1683^4
 ;;^UTILITY(U,$J,358.3,33686,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33686,1,3,0)
 ;;=3^Obesity d/t Excess Calories NEC
 ;;^UTILITY(U,$J,358.3,33686,1,4,0)
 ;;=4^E66.09
 ;;^UTILITY(U,$J,358.3,33686,2)
 ;;=^5002827
 ;;^UTILITY(U,$J,358.3,33687,0)
 ;;=E66.1^^151^1683^1
 ;;^UTILITY(U,$J,358.3,33687,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33687,1,3,0)
 ;;=3^Drug-Induced Obesity
 ;;^UTILITY(U,$J,358.3,33687,1,4,0)
 ;;=4^E66.1
 ;;^UTILITY(U,$J,358.3,33687,2)
 ;;=^5002828
 ;;^UTILITY(U,$J,358.3,33688,0)
 ;;=E66.2^^151^1683^3
 ;;^UTILITY(U,$J,358.3,33688,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33688,1,3,0)
 ;;=3^Morbid Obesity w/ Alveolar Hypoventilation
 ;;^UTILITY(U,$J,358.3,33688,1,4,0)
 ;;=4^E66.2
 ;;^UTILITY(U,$J,358.3,33688,2)
 ;;=^5002829
 ;;^UTILITY(U,$J,358.3,33689,0)
 ;;=99201^^152^1684^1
 ;;^UTILITY(U,$J,358.3,33689,1,0)
 ;;=^358.31IA^2^2
